What the Endocrinologist Needs to Know About the Diagnosis and Management of Nonalcoholic Fatty Liver Disease (NAFLD) and NASH

Dr. Cusi is a Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at The University of Florida at Gainesville, and at the Veterans Administration Medical Center at Gainesville, Fla. (2011–present). He completed his medical training and residency in Buenos Aires, Argentina, and fellowship in endocrinology at Baylor College of Medicine, Houston, Texas. He worked after his training at the University of San Antonio Health Science Center, Texas (1992–2011) on the role of defects in insulin secretion/insulin resistance in the development of T2DM and later focused on the underlying mechanisms and new treatments for nonalcoholic fatty liver disease (NAFLD) in T2DM.

Dr. Cusi has published over 200 original articles, editorials, reviews, and book chapters in the fields of diabetes, obesity, and liver disease. He has contributed to several guidelines in NAFLD. His basic and clinical research programs in diabetes and fatty liver disease include funding from the NIH and from industry examining new treatments for NASH. The University of Florida awarded him in 2015 two awards, the Exemplary Teacher Award and the Clinical Research Award for Outstanding Achievement, Research Discovery, and Productivity. In 2020, he received the American Association of Clinical Endocrinologists (AACE) Jack Baskin, MD, Endocrine Teaching Award.